Austrocortirubin

Austrocortirubin

SCHEMBL29357393

COc1cc(O)c2c(c1O)C(=O)c1cc(C)ccc1C2=O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 3/20 0.56
▸ MAPT P10636 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ PIM1 P11309 2/20 0.49
▸ MAOA P21397 4/20 0.46
▸ MAOB P27338 2/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ ALOX15 P16050 2/20 0.45
▸ TTR P02766 1/20 0.45
▸ CYP1A1 P04798 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ HSPD1 P10809 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Austrocortirubin SCHEMBL23199031 1.00 LCK (0.56) LCKMAPTMEN1KMT2ANPC1
SCHEMBL29709363 0.84 PIM1 (0.69) LCKMAPTMEN1KMT2ANPC1
SCHEMBL23198970 0.82 MAPT (0.47) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL16226054 0.80 EPHX2 (0.57) LCKMAPTMEN1KMT2ANPC1
SCHEMBL375798 0.79 LCK (0.67) LCKMAPTMEN1KMT2ANPC1
SCHEMBL31265528 0.79 LCK (0.67) LCKMAPTMEN1KMT2ANPC1
SCHEMBL30961641 0.78 ELANE (0.55) LCKMAPTMEN1KMT2ANPC1
SCHEMBL16932394 0.78 ELANE (0.55) LCKMAPTMEN1KMT2ANPC1
SCHEMBL28872297 0.77 EPHX2 (0.63) LCKMAPTMEN1KMT2ANPC1
SCHEMBL2137144 0.77 PSMB8 (0.42) MAPTMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3943085-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2022-01-26 — — EP claimed
EP-4536139-A1 DEVICES AND METHODS OF MAKING AND USE THEREOF The Methodist Hospital (US) 2025-04-16 — — EP disclosed
EP-4444280-A1 DIAMINO LIPID (DAL) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING AN IMMUNOTHERAPEUTIC AGENT Ohio State Innovation Foundation (US) 2024-10-16 — — EP disclosed
WO-2023244821-A1 DEVICES AND METHODS OF MAKING AND USE THEREOF THE METHODIST HOSPITAL SYSTEM (US) 2023-12-21 — — WO disclosed
WO-2023107400-A1 DIAMINO LIPID (DAL) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING AN IMMUNOTHERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-06-15 — — WO disclosed
EP-3943085-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2022-01-26 — — EP disclosed
Send feedback